Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs

International Journal of Clinical and Laboratory Research

Volumn 29, Issue 2, 1999, Pages 64-67

  Iskra, M ^a   Majewski, W ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ceruloplasmin; Copper; Ischemia; Superoxide dismutase; Zinc

Indexed keywords

CERULOPLASMIN; COPPER; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; ZINC;

AGED; ARTICLE; BLOOD; CHRONIC DISEASE; ENZYMOLOGY; ERYTHROCYTE; FEMALE; HUMAN; ISCHEMIA; LEG; MALE; MIDDLE AGED; VASCULARIZATION;

AGED; CERULOPLASMIN; CHRONIC DISEASE; COPPER; ERYTHROCYTES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; ZINC;

EID: 0032854554     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050065     Document Type: Article

References (16)

1. Ford PJ. Cardiovascular pathophysiology. Peripheral vascular disease. In: Anderson Price S, McCarty Wilson L, eds. Pathophysiology. Clinical concepts of disease processes. New York: McGraw-Hill; 1982:384-392.
2. Visioli F, Galli C. Evaluating oxidation processes in relation to cardiovascular disease: a current review of oxidant/antioxidant methodology. Nutr Metab Cardiovasc Dis 1997; 7:459.
3. Inoue M. Protective mechanism against reactive oxygen species. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The liver: biology and pathobiology. 3rd edn. New York: Raven; 1994:443-459.
4. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97.
5. Harris ED. Regulation of antioxidant enzymes. FASEB J 1992; 6:2675.
6. Fey GH, Hocke GM, Wilson DR, Ripperger JA, Juan T S-C, Cui M-Z, Darlington GJ. Cytokines and the acute phase response of the liver. In: Arias LM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The liver: biology and pathobiology. 3rd edn. New York: Raven; 1994:113-143.
7. Iskra M, Patelski J, Majewski W. Relationship of calcium, magnesium, zinc and copper concentrations in the arterial wall and serum in atherosclerosis obliterans and aneurysm. J Trace Elem Med Biol 1997; 11:248.
8. Schosinsky HP, Lehmann HP, Beeler MF, Measurement of ceruloplasmin from its oxidase activity in serum by o-dianisidine dihydrochloride. Clin Chem 1974; 20:1556.
9. Slater TF. Overview of methods used for detection of lipid peroxidation. Methods Enzymol 1984; 105:283.
10. Iskra M, Patelski J, Majewski W. Concentrations of calcium, magnesium, zinc and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men. J Trace Elem Electrolytes Health Dis 1993; 7: 185.
11. Gutteridge JMC. Antioxidant properties of ceruloplasmin towards iron - and copper - dependent oxygen radical formation. FEBS Lett 1983; 157:37.
12. Lamb DJ, Leake DS. Acidic pH enables ceruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Lett 1994; 338:122.
13. DiSilvestro RA, Marten JT, Shekhan M. Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase in free-living rheumatiod arthritis patients. J Am Coll Nutr 1992; 11:177.
14. DiSilvestro RA, Marten JT. Effects of inflammation and copper intake on rat liver and erythrocyte Cu,Zn-superoxide dismutase activity levels. J Nutr 1990; 120: 1223.
15. Wagner TL, DiSilvestro RA, Medeiros DM. Marginal copper intake and inflammation effects on copper enzyme activities in rats. J Trace Elem Exp Med 1995; 8: 41.
16. Płonka A, Metodiewa D, Zgirski A, Hilewicz M, Leyko W. ESR evidence of superoxide radical dismutation of human ceruloplasmin. Biochem Biophys Res Commun 1980; 95: 978.